NCT02012140View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI

PHASE4UnknownINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2015

Conditions

Cardiovascular DiseaseStable AnginaMyocardial InfarctionCoronary Artery Disease

Interventions

DRUG

ticagrelor

Trial Locations (1)

21215

Sinai Center for Thrombosis Research, Baltimore

Sponsors

Lead Sponsor

LifeBridge Health

All Listed Sponsors

lead

LifeBridge Health

OTHER

NCT02012140 - Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI | Biotech Hunter | Biotech Hunter